Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls

Abstract Objective Recent studies have demonstrated an altered expression of certain microRNAs in patients with rheumatoid arthritis (RA) as well as their first-degree relatives (FDRs) compared to healthy controls (HCs), suggesting a role of microRNA in the progression of the disease. To corroborate...

Full description

Bibliographic Details
Published in:Clinical Rheumatology
Main Authors: Renman, Emma, Brink, Mikael, Ärlestig, Lisbeth, Rantapää-Dahlqvist, Solbritt, Lejon, Kristina
Other Authors: Vetenskapsrådet, Stiftelsen Konung Gustaf V:s 80-årsfond, Reumatikerförbundet, Umeå Universitet
Format: Article in Journal/Newspaper
Language:English
Published: Springer Science and Business Media LLC 2020
Subjects:
Online Access:http://dx.doi.org/10.1007/s10067-020-05502-9
https://link.springer.com/content/pdf/10.1007/s10067-020-05502-9.pdf
https://link.springer.com/article/10.1007/s10067-020-05502-9/fulltext.html
id crspringernat:10.1007/s10067-020-05502-9
record_format openpolar
spelling crspringernat:10.1007/s10067-020-05502-9 2023-05-15T17:45:08+02:00 Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls Renman, Emma Brink, Mikael Ärlestig, Lisbeth Rantapää-Dahlqvist, Solbritt Lejon, Kristina Vetenskapsrådet Stiftelsen Konung Gustaf V:s 80-årsfond Reumatikerförbundet Umeå Universitet 2020 http://dx.doi.org/10.1007/s10067-020-05502-9 https://link.springer.com/content/pdf/10.1007/s10067-020-05502-9.pdf https://link.springer.com/article/10.1007/s10067-020-05502-9/fulltext.html en eng Springer Science and Business Media LLC https://creativecommons.org/licenses/by/4.0 https://creativecommons.org/licenses/by/4.0 CC-BY Clinical Rheumatology volume 40, issue 6, page 2387-2394 ISSN 0770-3198 1434-9949 General Medicine Rheumatology journal-article 2020 crspringernat https://doi.org/10.1007/s10067-020-05502-9 2022-01-04T13:00:34Z Abstract Objective Recent studies have demonstrated an altered expression of certain microRNAs in patients with rheumatoid arthritis (RA) as well as their first-degree relatives (FDRs) compared to healthy controls (HCs), suggesting a role of microRNA in the progression of the disease. To corroborate this, a set of well-characterized RA families originating from northern Sweden were analyzed for differential expression of a selected set of microRNAs. Method MicroRNA was isolated from frozen peripheral blood cells obtained from 21 different families and included 26 RA patients, 22 FDRs, and 21 HCs. Expression of the selected microRNAs miR-22-3p, miR-26b-5p, miR-34a-3p, miR-103a-3p, miR-142-3p, miR-146a-5p, miR-155, miR-346, and miR-451a was determined by a two-step quantitative real-time polymerase chain reaction (qRT-PCR). Statistical analysis including clinical variables was applied. Results Out of the nine selected microRNAs that previously have been linked to RA, we confirmed four after adjusting for age and gender, i.e., miR-22-3p ( p = 0.020), miR-26b-5p ( p = 0.018), miR-142-3p ( p = 0.005), and miR-155 ( p = 0.033). Moreover, a significant trend with an intermediate microRNA expression in FDR was observed for the same four microRNAs. In addition, analysis of the effect of corticosteroid use showed modulation of miR-103a-3p expression. Conclusions We confirm that microRNAs seem to be involved in the development of RA, and that the expression pattern in FDR is partly overlapping with RA patients. The contribution of single microRNAs in relation to the complex network including all microRNAs and other molecules is still to be revealed. Key Points • Expression levels of miR-22-3p, miR-26b-5p, miR-142-3p, and miR-155 were significantly altered in RA patients compared to those in controls. • In first-degree relatives, a significant trend with an intermediate microRNA expression in FDR was observed for the same four microRNAs. Article in Journal/Newspaper Northern Sweden Springer Nature (via Crossref) Clinical Rheumatology 40 6 2387 2394
institution Open Polar
collection Springer Nature (via Crossref)
op_collection_id crspringernat
language English
topic General Medicine
Rheumatology
spellingShingle General Medicine
Rheumatology
Renman, Emma
Brink, Mikael
Ärlestig, Lisbeth
Rantapää-Dahlqvist, Solbritt
Lejon, Kristina
Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
topic_facet General Medicine
Rheumatology
description Abstract Objective Recent studies have demonstrated an altered expression of certain microRNAs in patients with rheumatoid arthritis (RA) as well as their first-degree relatives (FDRs) compared to healthy controls (HCs), suggesting a role of microRNA in the progression of the disease. To corroborate this, a set of well-characterized RA families originating from northern Sweden were analyzed for differential expression of a selected set of microRNAs. Method MicroRNA was isolated from frozen peripheral blood cells obtained from 21 different families and included 26 RA patients, 22 FDRs, and 21 HCs. Expression of the selected microRNAs miR-22-3p, miR-26b-5p, miR-34a-3p, miR-103a-3p, miR-142-3p, miR-146a-5p, miR-155, miR-346, and miR-451a was determined by a two-step quantitative real-time polymerase chain reaction (qRT-PCR). Statistical analysis including clinical variables was applied. Results Out of the nine selected microRNAs that previously have been linked to RA, we confirmed four after adjusting for age and gender, i.e., miR-22-3p ( p = 0.020), miR-26b-5p ( p = 0.018), miR-142-3p ( p = 0.005), and miR-155 ( p = 0.033). Moreover, a significant trend with an intermediate microRNA expression in FDR was observed for the same four microRNAs. In addition, analysis of the effect of corticosteroid use showed modulation of miR-103a-3p expression. Conclusions We confirm that microRNAs seem to be involved in the development of RA, and that the expression pattern in FDR is partly overlapping with RA patients. The contribution of single microRNAs in relation to the complex network including all microRNAs and other molecules is still to be revealed. Key Points • Expression levels of miR-22-3p, miR-26b-5p, miR-142-3p, and miR-155 were significantly altered in RA patients compared to those in controls. • In first-degree relatives, a significant trend with an intermediate microRNA expression in FDR was observed for the same four microRNAs.
author2 Vetenskapsrådet
Stiftelsen Konung Gustaf V:s 80-årsfond
Reumatikerförbundet
Umeå Universitet
format Article in Journal/Newspaper
author Renman, Emma
Brink, Mikael
Ärlestig, Lisbeth
Rantapää-Dahlqvist, Solbritt
Lejon, Kristina
author_facet Renman, Emma
Brink, Mikael
Ärlestig, Lisbeth
Rantapää-Dahlqvist, Solbritt
Lejon, Kristina
author_sort Renman, Emma
title Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
title_short Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
title_full Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
title_fullStr Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
title_full_unstemmed Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
title_sort dysregulated microrna expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
publisher Springer Science and Business Media LLC
publishDate 2020
url http://dx.doi.org/10.1007/s10067-020-05502-9
https://link.springer.com/content/pdf/10.1007/s10067-020-05502-9.pdf
https://link.springer.com/article/10.1007/s10067-020-05502-9/fulltext.html
genre Northern Sweden
genre_facet Northern Sweden
op_source Clinical Rheumatology
volume 40, issue 6, page 2387-2394
ISSN 0770-3198 1434-9949
op_rights https://creativecommons.org/licenses/by/4.0
https://creativecommons.org/licenses/by/4.0
op_rightsnorm CC-BY
op_doi https://doi.org/10.1007/s10067-020-05502-9
container_title Clinical Rheumatology
container_volume 40
container_issue 6
container_start_page 2387
op_container_end_page 2394
_version_ 1766147915157340160